Real-Time, Label-Free Assessment of HER2-targeted Antibody-Drug Conjugate Therapies

Real-Time, Label-Free Assessment of HER2-targeted Antibody-Drug Conjugate Therapies
Download

Authors: Denise Sullivan, Danielle Califano, Benjamin Streeter, Austin Passaro, Stacie Chvatal, and Daniel Millard

Axion BioSystems, Atlanta, GA, USA

Presented by Danielle Califano on May 14th, 2025 at ASGCT 2025

Related Resources
Branched pegylated linker-auristatin to control hydrophobicity for the production of homogeneous minibody-drug conjugate against HER2-positive breast cancer
Imaging CAR-NK cells targeted to HER2 ovarian cancer with human sodium-iodide symporter-based positron emission tomography
Metformin encapsulating immunoliposomes conjugated with anti-TROP 2 antibody fragments for the active targeting of triple negative breast cancer

Related Products

Software

Impedance Module

Track cell proliferation, viability, barrier function, immune cell-mediated killing, viral cytopathic effects, and more

Learn more >>
Impedance software module for Axion BioSystems Maestro Z systems
Consumable

CytoView-Z Plate

The Maestro impedance plate with a transparent well bottom for cell visualization and assay multiplexing

Learn more >>
CytoView Z plate from Axion BioSystems for impedance assays on Maestro Z systems